Advanced Analytical CRO. We provide analytical services to support the pharmaceutical, biopharmaceutical, and chemical industries at every stage of drug development. AMSbiopharma is the alternative for preclinical and quality control services, providing precision and reliability at every stage.
Since our origin in 2008 as the most representative company of the AMSlab Group, it stands out for our customer orientation and our ability to offer both standard and specific analytical solutions for problems that arise during new developments. Today, AMSbiopharma supports numerous companies in their troubleshooting processes and their routine work.
Please consult our Team members on https://amsbiopharma.com/amsbiopharma/
At AMSbiopharma, we divide our services into two large blocks:
- R&D and Preclinical: Advanced analytical support for drug research and preclinical development.
- Quality Control: Comprehensive services to ensure the highest standards
of quality and safety.
we offer advanced bioanalytical and metabolomics services to support drug development. Using UPLC-MS/MS, we provide precise analyses for DMPK, biomarker identification, and lipidomics, delivering insights to accelerate your research.
Moreover, we provide specialized quality control services to ensure the safety and efficacy of pharmaceutical products. From drug impurity analysis to protein and nucleic acid-based biopharmaceutical testing, we use advanced techniques like UPLC-MS/MS and ICP-MS to meet the highest industry standards and regulatory requirements.
Below you can see our catalog of services:
R&D and Preclinical:
- Bioanalysis and biomarkers.
- Metabolomics and lipidomics.
- Contract purification services.
Quality Control:
- Drug impurities.
- Analytical Support.
- Analysis of protein-based pharmaceuticals.
- Analysis of nucleic acid-based biopharmaceuticals.
- ICP-MS Analysis.
- Quality control & stabilities.
- Microbiological control.
- Medical cannabis.
At our laboratory, we understand that close and fluid communication is critical to the success of our projects. At AMSbiopharma, we pride ourselves on offering personalized and direct attention, ensuring that you always have access to our experts and the information you need, when you need it. We are committed to being more than just a supplier; we aim to be a true strategic partner that understands your needs and works with you to achieve exceptional results. In addition, our advanced analytical solutions are designed to integrate efficiently into your processes, providing accurate and reliable results that drive your pharmaceutical projects forward.
As a CRO laboratory specialized in advanced analytics, we help the pharmaceutical, biopharmaceutical and chemical industries during the drug development process.
Pharmaceutical and biopharmaceutical industry:
• Companies that develop and manufacture medicines.
• Laboratories that need analytical services for quality control, preclinical and clinical studies.
Chemical industry:
• Companies that produce active ingredients (APIs) or excipients for drugs.
• Industries that need characterization and control of impurities.
ICH Q8 guideline for pharmaceutical development: analytical strategies for quality by design in complex drug modalities
AMSbiopharma
Peptide purification in drug development: methods, techniques, and analytical strategies
AMSbiopharma
Metabolomics and lipidomics in drug discovery and development: analytical approaches for biomarker discovery and preclinical research
AMSbiopharma
Drug development timeline: how early characterization prevents regulatory delays
AMSbiopharma
Chemistry, Manufacturing, and Controls (CMC) in the drug development process: analytical strategies to support Investigational New Drug (IND) readiness and regulatory progression
AMSbiopharma
Analytical strategies for gene and cell therapy products: From characterization to regulatory expectations
AMSbiopharma
EMA’s updated nitrosamines guideline: Implications for acceptable intake limits and analytical strategies
AMSbiopharma
Designing 'fit-for-purpose' quality control protocols for biologics and nucleic acid therapeutics
AMSbiopharma
Outsourcing as a biotech: How analytical CROs drive efficiency, compliance, and speed in drug development
AMSbiopharma
Implementation of UPLC‑MS/MS workflows in peptide therapeutics: from method development to regulatory submission
AMSbiopharma
